CIK 0001764013
- Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832771572
- Phone
- +1 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $895,852
- in 9 filings, $173K under 10b5-1 plans
Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-17 | Macias William L. Chief Medical Officer | Sale | −2,362 | $29.64 | $70K | 372,041 |
| 2024-07-17 | Macias William L. Chief Medical Officer | Sale | −147 | $30.55 | $4K | 371,894 |
| 2024-07-17 | Macias William L. Chief Medical Officer | Sale | −504 | $29.64 | $15K | 371,390 |
| 2024-07-17 | Macias William L. Chief Medical Officer | Sale | −31 | $30.55 | $947 | 371,359 |
| 2024-07-17 | Barnett Eva Renee Chief Financial Officer | Sale | −2,939 | $29.64 | $87K | 347,728 |
| 2024-07-17 | Barnett Eva Renee Chief Financial Officer | Sale | −184 | $30.55 | $6K | 347,544 |
| 2024-07-17 | Butchko Julia G. Chief Development Officer | Sale | −2,698 | $29.64 | $80K | 444,155 |
| 2024-07-17 | Butchko Julia G. Chief Development Officer | Sale | −169 | $30.55 | $5K | 443,986 |
| 2024-07-17 | Salzmann Peter Chief Executive Officer | Sale | −8,175 | $29.64 | $242K | 1,023,922 |
| 2024-07-17 | Salzmann Peter Chief Executive Officer | Sale | −510 | $30.55 | $16K | 1,023,412 |
| 2024-07-09 | Barnett Eva Renee Chief Financial Officer | Sale | −4,747 | $28.06 | $133K | 350,667 |
| 2024-07-09 | Butchko Julia G. Chief Development Officer | Sale | −1,527 | $28.06 | $43K | 446,853 |
| 2024-07-09 | Salzmann Peter Chief Executive Officer | Sale | −4,619 | $28.06 | $130K | 1,032,097 |
| 2024-05-22 | Barnett Eva Renee Chief Financial Officer | Sale | −4,042 | $29.65 | $120K | 355,414 |
| 2024-05-22 | Salzmann Peter Chief Executive Officer | Sale | −16,163 | $29.65 | $479K | 1,036,716 |
| 2024-05-22 | Butchko Julia G. Chief Development Officer | Sale | −3,247 | $29.65 | $96K | 448,380 |
| 2024-05-22 | Macias William L. Chief Medical Officer | Sale | −3,247 | $29.65 | $96K | 374,403 |
| 2024-05-22 | Levine Mark S. Chief Legal Officer | Sale | −3,242 | $29.65 | $96K | 339,914 |
| 2024-04-24 | Geffner Michael Chief Medical Officer | Sale | −3,261 | $28.90 | $94K | 141,616 |
| 2024-04-24 | Stout Jay S Chief Technology Officer | Sale | −7,239 | $28.90 | $209K | 147,739 |
Page 12 of 18 · 351 trades